8.8 Use in Patients with Chronic Conditions Efficacy of TAMIFLU in the treatment of influenza in patients with chronic cardiac disease and/or respiratory disease was evaluated in one randomized, placebo-controlled clinical trial
March 5, 2026: Rybelsus Manufacturer, Novo Nordisk, Cited for Not Reporting Adverse Drug Events to FDA The FDA has sent a warning letter to Novo Nordisk because it says the companys written policies for tracking, reporting, and evaluating postmarketing adverse drug experiences to the FDA were insufficient
Our Products Tirzepatide Semaglutide NAD+ Injection NAD+ Nasal Spray Lipo-B + B12 Lipo-C Vitamin B-12 Glutathione Metformin Sermorelin Tretinoin Before receiving any medication, patients are required to complete an online assessment and have a consultation with one of our healthcare providers
Besides, retatrutide is not yet available for public use, and when it is, drug interaction and safety will have to be carried out to determine if it is safe to use with other weight loss medications like semaglutide